03/28/2025 10:17 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2025 9:48 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2025 8:43 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2025 7:00 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/24/2025 8:54 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/03/2025 11:29 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/27/2025 9:00 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/24/2025 12:58 PM | Charmquark TWEE (Filed by) ImmunoPrecise Antibodies (Subject)
| Form SCHEDULE 13G/A | |
01/22/2025 9:30 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/17/2025 10:30 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/03/2025 9:20 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for IPA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter.
|
12/23/2024 8:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/10/2024 7:36 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/10/2024 7:37 AM | ImmunoPrecise Antibodies (Filer)
| Form 20-F/A | |
12/10/2024 7:33 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024 7:33 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024 8:17 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024 7:54 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024 6:36 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024 8:08 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024 2:25 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2024 8:39 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2024 7:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 8:13 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 1:40 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 8:04 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 8:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024 8:41 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/23/2024 7:01 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024 8:21 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/18/2024 11:15 PM | ImmunoPrecise Antibodies (Filer)
| Form EFFECT | |
08/06/2024 4:16 PM | ImmunoPrecise Antibodies (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
07/30/2024 12:57 PM | ImmunoPrecise Antibodies (Filer)
| Form D Notice of Exempt Offering of Securities | |
07/29/2024 7:35 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2024 7:38 AM | ImmunoPrecise Antibodies (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
07/23/2024 8:55 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/16/2024 8:41 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024 7:32 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024 8:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024 8:12 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2024 12:01 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Now I look stupid. Real stupid... (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
06/10/2024 1:23 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |